NEUROIMAGING MONITORING FOR EVALUATING THE EFFECTIVENESS OF LYMPHOTROPIC THERAPY IN STROKE

The objects of the study were 65 patients with stroke, whose age ranged from 32 to 65 years. The study included patients with hemorrhagic (n=32) and ischemic (n=33) forms of stroke. The most important criterion for evaluating the effectiveness of the ongoing lymphotropic decongestant in combination with standard therapy was the timing of recovery of the level of consciousness, which was recorded according to GCS and according to MSCT data, which allows dynamic and objective control of cerebral edema.